Weight Loss Medication: Insurance Coverage Options Explored

does any insurance cover weight loss medication

Weight loss medications can be expensive, with monthly costs ranging from $900 to $1,300. So, it's understandable that people would want to know if their insurance covers these drugs. Generally, insurance companies and employers who sponsor health coverage consider weight loss a cosmetic need rather than a medical one. Therefore, they don't cover weight loss medications. This goes for commercial insurers as well as Medicare and Medicaid. In fact, Medicare is prohibited by law from covering weight loss drugs due to past safety concerns. However, some employer-sponsored health plans do cover weight-loss medications, and it's worth contacting your insurer to find out if your plan is one of them.

Characteristics Values
Cost of weight-loss medication $1,300 for a month's supply
Cost without insurance Hundreds of dollars per month
Availability of generics Yes, for older weight-loss medications
Coverage by Medicare Prohibited by law
Coverage by Medicaid No coverage
Coverage by commercial insurers No coverage
Coverage by employer-sponsored health plans May exclude GLP-1 drugs
Coverage for weight-loss injectables Depends on insurer and medical officer
Coverage for FDA-approved drugs Depends on diagnosis
Side effects Nausea, vomiting, diarrhea, dizziness, mild tachycardia, headaches, constipation, and other gastrointestinal discomfort
Shortages Intermittent nationwide shortages reported

Explore related products

Phendimetrazine

$3 $8.7

Diethylpropion

$20 $116.7

Wegovy

$40

Phentermine

$8 $36.9

Contrave

$66 $183.9

Zepbound

$50 $1113

shunins

Medicare and Medicaid do not cover weight loss medication

As of 2025, Medicare does not cover prescription drugs that are used only for weight loss. This is due to past safety concerns, specifically the fallout from fen-phen in the 1990s, which led to rapid weight loss but was later found to cause heart valve damage. As a result, the federal government disallowed Medicare from covering drugs viewed as having risks that outweighed the benefits, particularly cosmetic benefits. Medicare is prohibited by law from covering weight loss drugs.

However, if the medication is also approved by the FDA for additional health benefits, such as treating Type 2 diabetes, cardiovascular disease, or sleep apnea, it may be covered under Medicare Part D. Medicare Advantage plans may also include additional benefits that can aid in weight loss, such as fitness programs. Additionally, Medicare Part B covers obesity behavioural therapy in some cases.

In November 2024, the Biden administration proposed a rule that would have allowed Medicare and Medicaid to cover weight loss medications specifically to treat obesity. This proposal was rejected by the incoming Trump administration in April 2025. The Centers for Medicare and Medicaid Services stated that they believed expanding coverage "is not appropriate at this time" but have not ruled out considering future policy options.

Medicaid, like Medicare, does not currently cover weight loss medication. The Biden administration's proposal, if accepted, would have expanded access to weight loss drugs for millions of people with Medicaid coverage. However, with the rejection of the proposal, Medicaid coverage for weight loss drugs remains unchanged.

shunins

Weight loss injectables are not always covered by insurance

Some employers choose to exclude GLP-1 drugs from employer-sponsored health plans. However, if a patient has a type 2 diabetes diagnosis, their insurance may cover the cost of injectables that are only FDA-approved to treat type 2 diabetes, such as Mounjaro (tirzepatide) and Ozempic (semaglutide). Additionally, if a patient has an obesity-related medical problem, such as high cholesterol or high blood pressure, their health insurer may be more likely to cover the cost of weight loss injectables.

Prior authorization (PA) is required by some prescription insurance plans to cover certain medications. For these plans, a health care provider must submit a form to the insurance company to seek approval for coverage. Even with insurance, weight loss injectables can still cost hundreds of dollars per month. Without insurance, these injectables can cost $1,300 or more for a month's supply.

If a patient's insurance denies coverage for weight loss injectables, they have the right to appeal. There are two types of appeals: internal appeal and external review. Additionally, if a patient's insurance does not cover weight loss injectables, their care team may help them identify other affordable options.

shunins

Some GLP-1 medications are unaffordable

The affordability of weight-loss medication is a pressing issue for many. While some older weight-loss medications are more affordable due to available generics, the newer drugs can be extremely expensive. This is particularly true of GLP-1 medications, which can cost hundreds of dollars a month, sometimes up to $1,000, and are often not covered by insurance.

GLP-1 agonists, such as Ozempic and Wegovy, have become popular for weight loss and diabetes management, but their high cost has sparked debates about their accessibility and affordability. Indeed, the current system in the US relies largely on the patient's ability to pay, which is not ethical, as it means that only those in higher-income areas can access these drugs.

Some insurance companies do cover GLP-1s, and the Biden Administration has proposed expanding access to weight-loss drugs for those on Medicare and Medicaid. However, many people are unable to get their insurance to cover these medications and cannot afford the high out-of-pocket costs. This has led to some people turning to compounded forms of popular GLP-1s, which are more affordable but may not be safe or effective.

To address the issue of affordability, experts have proposed several guidelines for future policies. These include using up-to-date cost-effectiveness analyses, setting priorities for coverage based on need rather than issuing blanket denials, and lowering prices while keeping them high enough to incentivize innovation.

While some GLP-1 medications are covered by Medicare and insurance plans, the high cost of these drugs can still be a barrier for many people. It is important for patients to have access to affordable weight-loss medications, as the alternative of unaffordable medication can lead to non-adherence and negative health outcomes.

shunins

Side effects of weight loss medication

Weight loss medication can come with a variety of side effects, and these can influence a patient's comfort and adherence to the treatment. The side effects will vary depending on the medication, and while some are mild and temporary, others can be more serious.

The oldest and most widely used weight-loss medication is phentermine. It has been used since 1959 and works by decreasing hunger. However, it is not suitable for those with hyperthyroidism, glaucoma, or heart disease, or for those who have had a stroke. Side effects include headache, overstimulation, high blood pressure, insomnia, rapid or irregular heart rate, and tremors.

Orlistat is another weight loss medication that works by blocking the absorption of dietary fats. The most common side effects are oily discharge from the rectum, flatulence with discharge, increased defecation, and fecal incontinence.

Tirzepatide was initially approved to treat type 2 diabetes, but in 2023 it was approved for weight loss. Common side effects include constipation, upset stomach, bloating, and diarrhea. However, more serious potential side effects include stomach, kidney, gallbladder problems, pancreatitis, or hypoglycemia.

GLP-1 agonists, which include tirzepatide, have been endorsed by celebrities such as Oprah Winfrey, Tracy Morgan, and Amy Schumer. Nearly half of the people who take these medications experience gastrointestinal side effects such as nausea, vomiting, acid reflux, bloating, stomach cramps, diarrhea, and/or constipation.

To manage these side effects, doctors recommend making dietary changes, such as limiting high-fat and greasy foods, sugary drinks, and spicy foods. Eating smaller portions and listening to your body's signs of fullness can also help.

shunins

Weight loss medication prescriptions are increasing

Firstly, the emergence of new prescription weight loss drugs has sparked interest among those seeking to manage their weight. Initially developed to treat type 2 diabetes, these drugs have gained attention for their significant weight loss effects. Additionally, celebrity endorsements from prominent figures such as Oprah Winfrey, Tracy Morgan, and Amy Schumer have fuelled public interest in weight loss medications.

Secondly, an increasing number of individuals are turning to prescription drugs as a means to address weight-related health issues. Obesity and being overweight are associated with various health problems, including joint pain and sleep apnea. Weight loss medications, when combined with lifestyle and behaviour changes, can help individuals lose weight and improve their overall health. Research shows that adults who incorporate prescription medications into their lifestyle programs lose 3% to 12% more of their starting body weight compared to those who rely solely on lifestyle changes.

However, it is important to note that weight loss medications are not without their concerns. In the past, some weight management drugs were linked to serious health issues, resulting in their removal from the market. While current medications are generally considered safer, they can still cause side effects such as nausea, vomiting, diarrhoea, dizziness, mild tachycardia, and headaches. Additionally, the cost of these medications can be prohibitive, with a month's supply of certain drugs costing over $1,000. While some individuals may have their medication covered by insurance, many insurers do not cover weight loss treatments, considering them a cosmetic rather than a medical necessity.

Despite the potential drawbacks, the demand for weight loss medications continues to grow. Public opinion polls indicate that a large majority of adults believe that health insurance should cover the cost of these prescriptions for individuals diagnosed as overweight or obese. This sentiment is particularly strong among younger adults, who are willing to bear higher insurance premiums to ensure coverage for weight loss treatments. As a result, it is likely that weight loss medication prescriptions will continue to increase in the future, driven by a combination of public interest, trust in pharmaceutical companies, and the desire for improved health outcomes.

Frequently asked questions

Payers tend not to cover weight-loss medication. This includes commercial insurers, as well as Medicare and Medicaid. Medicare is prohibited by law from covering weight-loss medication due to past safety concerns. Many insurers and employers who sponsor health coverage consider weight loss a cosmetic need rather than a medical one.

Some weight-loss medications include Wegovy (semaglutide), Saxenda (liraglutide), and Zepbound (tirzepatide). These medications are GLP-1 receptor agonists and are often prescribed for chronic weight management. Other weight-loss drugs include Metformin, Naltrexone, and Bupropion.

Weight-loss medications can be expensive, with a month's supply costing $1,300 or more. Even with insurance, these medications can still cost hundreds of dollars per month.

Written by
Reviewed by

Explore related products

Share this post
Print
Did this article help you?

Leave a comment